CIK 0001583107
TBPH Theravance Biopharma, Inc.
Insider trading from SEC Form 4. Last filing 14 d ago. Close $17.03 on Sep 25, 2026, 0% from the 52-week low and 0% from the high.
Last 90 days
Net insider value
-$227k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$227k by 1 insider
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
TBPHSep 25, 2026 · close 17.03
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Theravance Biopharma, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS sell | $227k 13,314 shares | -6% | - | |
| 1Weak | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS sell | $36k 4,000 shares | -1% | - | |
| 21Weak | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS sell | $36k 4,000 shares | -1% | - |
Congressional trades
1 trade in TBPH disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
George Whitesides House · D-CA | Sale | TBPH Theravance Biopharma, Inc. - Ordinary Shares | $15k to $50k | Mar 24, 2025 / Apr 23, 2025 30 days after the trade | Clerk |
Transactions
The last 87 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Weiss Asset Management LP other | JOther Ordinary Share $0.00001 Par Valueindirect: See Footnote 2 | -7,457,060 | $17.00 | $127M | 0 | 14 d ago |
| Sep 23, 2026 | Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER | DDisposition to issuer Ordinary Shares | -204,966 | - | - | 131,875 | 18 d ago |
| Sep 23, 2026 | Susannah Gray director | DDisposition to issuer Ordinary Shares | -42,137 | - | - | 6,009 | 18 d ago |
| Sep 23, 2026 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | DDisposition to issuer Ordinary Shares | -124,414 | - | - | 89,062 | 18 d ago |
| Sep 23, 2026 | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Shares | -1,382,272 | - | - | 228,750 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Ordinary Shares | -58,065 | - | - | 6,009 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Ordinary Shares | -74,980 | - | - | 6,009 | 18 d ago |
| Sep 23, 2026 | Aine Miller SVP, DEV & HEAD OF IRE OFFICE | DDisposition to issuer Ordinary Shares | -93,108 | - | - | 96,718 | 18 d ago |
| Sep 23, 2026 | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | DDisposition to issuer Ordinary Shares | -223,917 | - | - | 131,251 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Ordinary Shares | -74,204 | - | - | 6,009 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Ordinary Shares | -91,204 | - | - | 6,009 | 18 d ago |
| Sep 23, 2026 | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Shares | -151,875 | - | - | 76,875 | 18 d ago |
| Sep 23, 2026 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | DDisposition to issuer Ordinary Shares | -89,062 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Aine Miller SVP, DEV & HEAD OF IRE OFFICE | DDisposition to issuer Ordinary Shares | -96,718 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER | DDisposition to issuer Ordinary Shares | -108,436 | - | - | 23,439 | 18 d ago |
| Sep 23, 2026 | Susannah Gray director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | DDisposition to issuer Ordinary Shares | -107,812 | - | - | 23,439 | 18 d ago |
| Sep 23, 2026 | Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER | DDisposition to issuer Ordinary Shares | -23,439 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Shares | -76,875 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | DDisposition to issuer Share Option (Right to Buy)derivative | -150,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -32,666 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Aine Miller SVP, DEV & HEAD OF IRE OFFICE | DDisposition to issuer Share Option (Right to Buy)derivative | -37,500 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | DDisposition to issuer Ordinary Shares | -23,439 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -17,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,500 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Sharesindirect: As Custodian | -23,400 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Sharesindirect: By Trust | -92,567 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Share Option (Right to Buy)derivative | -515,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 18 d ago |
| Sep 15, 2026 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | SOpen-market sale Ordinary Shares10b5-1 | -3,329 | $17.03 | $57k | 223,461 | 25 d ago |
| Sep 15, 2026 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | SOpen-market sale Ordinary Shares10b5-1 | -3,328 | $17.03 | $57k | 220,133 | 25 d ago |
| Sep 15, 2026 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | SOpen-market sale Ordinary Shares10b5-1 | -6,657 | $17.03 | $113k | 213,476 | 25 d ago |
| May 19, 2025 | Eran Broshy director | AGrant or award Ordinary Shares | +10,649 | $0.00 | $0 | 91,204 | May 21, 2025 |
| May 19, 2025 | Eran Broshy director | AGrant or award Share Option (Right to Buy)derivative | +24,258 | $0.00 | $0 | 24,258 | May 21, 2025 |
| Feb 28, 2025 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | AGrant or award Ordinary Shares | +75,000 | $0.00 | $0 | 374,038 | Mar 4, 2025 |
| Feb 28, 2025 | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | AGrant or award Ordinary Shares | +75,000 | $0.00 | $0 | 393,811 | Mar 4, 2025 |
| Feb 20, 2025 | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | FTax withholding Ordinary Shares | -14,534 | $9.66 | $140k | 318,811 | Feb 24, 2025 |
| Feb 10, 2025 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | AGrant or award Ordinary Shares | +5,283 | $0.00 | $0 | 314,848 | Feb 24, 2025 |
| Feb 20, 2025 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | FTax withholding Ordinary Shares | -15,810 | $9.66 | $153k | 299,038 | Feb 24, 2025 |
| Jan 21, 2025 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | SOpen-market sale Ordinary Shares10b5-1 | -4,000 | $9.00 | $36k | 309,565 | Jan 23, 2025 |
| Nov 20, 2024 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | FTax withholding Ordinary Shares | -9,178 | $9.97 | $92k | 313,565 | Nov 22, 2024 |
| Nov 20, 2024 | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | FTax withholding Ordinary Shares | -9,268 | $9.97 | $92k | 333,345 | Nov 22, 2024 |
| Nov 20, 2024 | Aine Miller SVP, DEV & HEAD OF IRE OFFICE | FTax withholding Ordinary Shares | -10,076 | $9.97 | $100k | 150,556 | Nov 22, 2024 |
| Nov 20, 2024 | Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER | FTax withholding Ordinary Shares | -8,477 | $9.97 | $85k | 312,889 | Nov 22, 2024 |
| Nov 20, 2024 | Rick E Winningham CHIEF EXECUTIVE OFFICER | FTax withholding Ordinary Shares | -15,997 | $9.97 | $159k | 1,811,095 | Nov 22, 2024 |
| Nov 14, 2024 | Rick E Winningham CHIEF EXECUTIVE OFFICER | AGrant or award Ordinary Shares | +3,193 | $9.57 | $31k | 1,827,092 | Nov 19, 2024 |
| Nov 11, 2024 | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | SOpen-market sale Ordinary Shares | -4,000 | $9.00 | $36k | 322,743 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Eran Broshydirector, other
- Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS
- Susannah Graydirector
- Brett A. GrimaudSVP, GEN COUNSEL AND SECRETARY
- Dean J Mitchelldirector
- Aine MillerSVP, DEV & HEAD OF IRE OFFICE
- Donal O'Connordirector
- Deepika Pakianathandirector
- Aziz SawafSVP & CHIEF FINANCIAL OFFICER
- Alsup Laurie Smaldonedirector
- Weiss Asset Management LPother
- Rick E WinninghamCHIEF EXECUTIVE OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.